Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.40 |
| ▸ | MEN1 | O00255 | 3/20 | 0.40 |
| ▸ | HPGD | P15428 | 4/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.39 |
| ▸ | METAP2 | P50579 | 1/20 | 0.36 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.35 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21831855 | 1.00 | KMT2A (0.40) | KMT2AMEN1HPGDLMNASMN1; SMN2 | |
| SCHEMBL82365 | 0.98 | KMT2A (0.40) | KMT2AMEN1HPGDLMNASMN1; SMN2 | |
| SCHEMBL1024555 | 0.97 | KMT2A (0.40) | KMT2AMEN1HPGDLMNASMN1; SMN2 | |
| Ammonia Solution, Strong SCHEMBL3101939 | 0.97 | KMT2A (0.40) | KMT2AMEN1HPGDLMNASMN1; SMN2 | |
| Water SCHEMBL25255612 | 0.97 | KMT2A (0.40) | KMT2AMEN1HPGDLMNASMN1; SMN2 | |
| SCHEMBL28205455 | 0.95 | ALDH1A1 (0.40) | KMT2AMEN1HPGDLMNASMN1; SMN2 | |
| SCHEMBL28106357 | 0.89 | KMT2A (0.35) | KMT2AMEN1HPGDLMNASMN1; SMN2 | |
| SCHEMBL28560287 | 0.87 | KMT2A (0.41) | KMT2AMEN1HPGDLMNASMN1; SMN2 | |
| SCHEMBL1830534 | 0.85 | CYP3A4 (0.41) | KMT2AMEN1HPGDLMNAALDH1A1 | |
| Hydrogen Sulfide SCHEMBL28875010 | 0.84 | KMT2A (0.37) | KMT2AMEN1HPGDLMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 122 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12030970-B2 | Curable composition and stereolithographic resin composition comprising same | KURARAY CO., LTD. (JP) | 2024-07-09 | — | — | US | disclosed |
| WO-2024096019-A1 | DENTAL ADHESIVE COMPOSITION | クラレノリタケデンタル株式会社 | 2024-05-10 | — | — | WO | disclosed |
| WO-2024053223-A1 | CARIOUS TOOTH STRUCTURE RECOVERY AGENT, AND DENTAL ADHESIVE KIT | クラレノリタケデンタル株式会社 | 2024-03-14 | — | — | WO | disclosed |
| EP-2979679-B1 | CURABLE COMPOSITION FOR DENTAL USE | KURARAY NORITAKE DENTAL INC (JP) | 2023-11-29 | — | — | EP | disclosed |
| US-11814454-B2 | Curable composition, and resin composition for stereolithography prepared therefrom | KURARAY CO., LTD. (JP) | 2023-11-14 | — | — | US | disclosed |
| WO-2023191112-A1 | DENTAL CURABLE COMPOSITION HAVING FAVORABLE COLOR COMPATIBILITY | クラレノリタケデンタル株式会社 | 2023-10-05 | — | — | WO | disclosed |
| WO-2023190931-A1 | RESIN COMPOSITION FOR STEREOLITHOGRAPHY | クラレノリタケデンタル株式会社 | 2023-10-05 | — | — | WO | disclosed |
| WO-2023127934-A1 | ENERGY-RAY-CURABLE COMPOSITION FOR THREE-DIMENSIONAL SHAPING USE, DENTAL STRUCTURE, MOUTHPIECE, TEETH-STRAIGHTENING MOUTHPIECE, AND METHOD FOR PRODUCING DENTAL STRUCTURE | クラレノリタケデンタル株式会社 | 2023-07-06 | — | — | WO | disclosed |
| WO-2023120610-A1 | DENTAL CURABLE COMPOSITION | クラレノリタケデンタル株式会社 | 2023-06-29 | — | — | WO | disclosed |
| WO-2023042912-A1 | METHOD FOR MANUFACTURING INTRAORAL APPLIANCE EQUIPPED WITH COATING, AND INTRAORAL APPLIANCE EQUIPPED WITH COATING | クラレノリタケデンタル株式会社 | 2023-03-23 | — | — | WO | disclosed |
| US-20100048761-A1 | POLYMERIZABLE MONOMER-CONTAINING COMPOSITION | KURARAY MEDICAL INC. (JP) | 2010-02-25 | — | — | US | disclosed |
| US-20100048762-A1 | COMPOSITION AND DENTAL MATERIAL | KURARAY MEDICAL INC. (JP) | 2010-02-25 | — | — | US | disclosed |
| US-20100036075-A1 | POLYMERIZABLE MONOMER-CONTAINING COMPOSITION | KURARAY MEDICAL INC. (JP) | 2010-02-11 | — | — | US | disclosed |
| EP-2133368-A1 | POLYMERIZABLE MONOMER, POLYMERIZABLE COMPOSITION AND DENTAL MATERIAL | Kuraray Medical Inc. (JP) | 2009-12-16 | — | — | EP | disclosed |
| EP-2112177-A1 | POLYMERIZABLE MONOMER-CONTAINING COMPOSITION | Kuraray Medical Inc. (JP) | 2009-10-28 | — | — | EP | disclosed |
| EP-2112178-A1 | POLYMERIZABLE MONOMER-CONTAINING COMPOSITION | Kuraray Medical Inc. (JP) | 2009-10-28 | — | — | EP | disclosed |
| EP-2108663-A1 | POLYMERIZABLE MONOMER, POLYMERIZABLE COMPOSITION AND DENTAL MATERIAL | Kuraray Medical Inc. (JP) | 2009-10-14 | — | — | EP | disclosed |
| EP-2108664-A1 | COMPOSITION AND DENTAL MATERIAL | Kuraray Medical Inc. (JP) | 2009-10-14 | — | — | EP | disclosed |
| EP-2070935-A1 | NOVEL COMPOUND, COMPOSITION COMPRISING THE SAME, AND PROCESS FOR PRODUCTION OF POLYMERIZABLE AMIDE | Kuraray Medical Inc. (JP) | 2009-06-17 | — | — | EP | disclosed |
| US-20090105361-A1 | Camphorquinone Derivative Having Acylphosphine Oxide Group, Photopolymerization Catalyst And Photo/Chemical Polymerization Catalyst Containing The Same And Hardenable Composition Contaning The Same | KABUSHIKI KAISHA SHOFU | 2009-04-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11814454-B2 | Curable composition, and resin composition for stereolithography prepared therefrom | WASF2, COPE, ARCN1 | KMT2A 2942/4885MEN1 3152/4885HPGD 878/4885 |
| US-20100048761-A1 | POLYMERIZABLE MONOMER-CONTAINING COMPOSITION | WDR82, PWWP2B, WDR5 | KMT2A 2288/4885MEN1 2863/4885HPGD 319/4885 |
| US-20100048762-A1 | COMPOSITION AND DENTAL MATERIAL | PHOSPHO1, PDS5B, ITGB5 | KMT2A 1690/4885MEN1 4053/4885HPGD 1766/4885 |
| US-20090105361-A1 | Camphorquinone Derivative Having Acylphosphine Oxide Group, Photopolymerization Catalyst And Photo/Chemical Polymerization Catalyst Containing The Same And Hardenable Composition Contaning The Same | POLQ, GAK, CAD | KMT2A 1026/4885MEN1 3924/4885HPGD 1024/4885 |
| US-12030970-B2 | Curable composition and stereolithographic resin composition comprising same | ARL1, ASH2L, VCL | KMT2A 1501/4885MEN1 2530/4885HPGD 3840/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.